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Abstract
Foveal hypoplasia, optic nerve decussation defects and anterior segment dysgenesis is an autosomal recessive disorder
arising from SLC38A8 mutations. SLC38A8 is a putative glutamine transporter with strong expression within the
photoreceptor layer in the retina. Previous studies have been limited due to lack of quantitative data on retinal development
and nystagmus characteristics. In this multi-centre study, a custom-targeted next generation sequencing (NGS) gene panel
was used to identify SLC38A8 mutations from a cohort of 511 nystagmus patients. We report 16 novel SLC38A8 mutations.
The sixth transmembrane domain is most frequently disrupted by missense SLC38A8 mutations. Ninety percent of our
cases were initially misdiagnosed as PAX6-related phenotype or ocular albinism prior to NGS. We characterized the retinal
development in vivo in patients with SLC38A8 mutations using high-resolution optical coherence tomography. All patients
had severe grades of arrested retinal development with lack of a foveal pit and no cone photoreceptor outer segment
lengthening. Loss of foveal specialization features such as outer segment lengthening implies reduced foveal cone density,
which contributes to reduced visual acuity. Unlike other disorders (such as albinism or PAX6 mutations) which exhibit a
spectrum of foveal hypoplasia, SLC38A8 mutations have arrest of retinal development at an earlier stage resulting in a more
under-developed retina and severe phenotype.
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Introduction
Phenotypical characteristics of foveal hypoplasia (FH) and
abnormalities of optic nerve decussation have previously
been described in association with albinism and albinism
syndromes due to disruption of the melanin biosynthesis
pathway (1). Al-Araimi et al. described a new recessively
inherited disorder called FH, optic nerve decussation defects and
anterior segment dysgenesis (FHONDA), which had significant
overlap of phenotypical characteristics with albinism. However,
in FHONDA, there were no features of cutaneous or ocular
hypopigmentation (2). Poulter et al. identified that mutations
of SLC38A8, a putative glutamine transporter gene found on
chromosomes 16q23.3–24.1, were causative of FHONDA (3).
This is thought to be part of a melanin-independent pathway
affecting foveal development.
To date, 17 SLC38A8 mutations have been described (3,4,5,6,7).
The mutational spectrum is varied (Fig. 1), and includes mis-
sense, nonsense and frameshift mutations. Splice mutations
have not been described. Infantile nystagmus (IN) and FH are the
most consistent phenotypes observed in all previously described
families. Optic nerve decussation defects are also likely to be a
consistent phenotype, however, not reported in all cases due to
lack of visual evoked potentials (VEP) in some cases (4,5). It is
hypothesized that more deleterious mutations may be associ-
ated with anterior segment dysgenesis (ASD) (5). Recently, two
patients with FHONDA were reported to have iris transillumina-
tion defects (TID). Both with compound heterozygous mutation
of SLC38A8; with an amino acid substitution at Thr308 (6). This
further blurs the phenotypical overlap between albinism and
FHONDA. The detailed phenotypical characteristics including
nystagmus features and degree of arrested retinal development
in SLC38A8 mutations have not been systematically analyzed in
relation to genotypes.
We studied 11 subjects from nine families with SLC38A8
mutations, which represents the largest number of families with
SLC38A8 mutations reported and describe for the first time the
detailed eye movement characteristics, foveal developmental




We identified a total of 17 SLC38A8 mutations in 11 affected
subjects from nine families (Table 1). The American College
of Medical Genetics (ACMG) classification of the variants and
segregation analyses are provided in Table 1. Sixteen of these
mutations were novel and one (c.101 T > G; p.(Met34Arg))
previously reported (2). The location of each of the mutations
is shown in the schematic in Figure 1. Of the nine families, two
had homozygous mutations (F7: c.101 T > G; p.(Met34Arg) and F8:
c.632 + 2 T > G). The remaining families (F1–F6), Korean in eth-
nicity, had compound heterozygous mutations. One Caucasian
British family (F9) also had a compound heterozygous mutation.
The six missense mutations resulting in amino acid sub-
stitutions at positions 215, 228, 231, 232, 285 and 376 not only
involve highly conserved residues that are invariant in Rat-
tus norvegicus, Mus musculus, Gallus gallus, Xenopus tropicalis and
Danio rerio (Supplementary Material, Fig. S1) but are also located
within invariant blocks of highly conserved residues. Thus sug-
gesting that mutations at these locations are critical to the nor-
mal function of the protein. The residues at position 228, 231 and
232 are within the sixth transmembrane domain, which appears
to be a commonly affected domain (previous mutations in this
domain: Glu233Lys (two separate reports) (3,6) and Val236Asp)
(3). Structural modelling shows that all amino acid substitutions,
except Trp215Leu, are within α-helices deep within the protein
structure. The Trp215 residue is located within a coil region in
the extracellular area between transmembrane domains 5 and 6
(Fig. 2). All amino acid substitutions are predicted to be desta-
bilizing (Fig. 2). The six missense mutations all have a CADD
score above 20.0 indicating they are predicted to be in the 1%
most deleterious substitutions that can be applied to the human
genome.
In our cohort, we identified three splice mutations. The
c.632 + 2 T > G and c.954-1G > C alters the splice donor (at exon
4–intron4 junction) and acceptor (at intron7–exon8 junction)
sites, respectively (Fig. 2). Both alter the strongly conserved
canonical donor (+1 and + 2 nucleotides) or acceptor (−1 and − 2
nucleotides) sites and are predicted to be pathological by
Figure 1. (A) Schematic representation of the SLC38A8 protein with 11 transmembrane domains and location of amino acid changes in relation to the protein
domains. Mutations in italics and with a solid black outline are ones reported in this study. Transmembrane domain 6 has recurrent missense mutations. c.995dupG:
p.(W333Mfs∗35) was a recurrent frameshift mutation reported in this study that was observed in three separate Korean families. Similarly, p.I32S is a recurrent mutation
(reported in six separate families) observed in both Indian and Karaite Jewish ethnicities.
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Figure 2. (A) Predicted wild type SLC38A8 protein 3D structure. (B and C) Location of the missense mutations resulting in amino acid substitutions at residue positions
34, 215, 228, 231, 232, 285 and 376. The residues 59–74 and 252–274 have been made see-through (C) to allow visualization of inner structure including transmembrane
domain 6. Residue 215 is located within a coil region in the extracellular area between transmembrane domains 5 and 6. (D) SLC38A8 gene structure and location of
novel splice mutations. (E) Schematic depicts location of nonsense mutations resulting in truncated protein. (F) Amino acid substitutions and predicted stability change
(G). The Gibbs free energy gap difference (G = Gm – Gw) between the mutant (Gm) and wild type (Gw) protein. Negative changes in G were predicted to
be destabilizing. Variants reported in this study are shown in red and italics. TM domain = transmembrane domain.
classical exon skipping and nonsense mediated decay (NMD).
The c.1214 + 5G > C mutation is predicted (Supplementary
Material, Fig. S2) to alter the wild type splice donor site (at
exon9–intron9 junction) (Fig. 2), and thus also pathological by
exon skipping and NMD.
The nonsense mutations Tyr186∗ and Gln322∗ predict trun-
cating proteins containing 43% and 74% of the protein, respec-
tively (Fig. 2). We identified a recurrent frameshift mutation
(c.995dupG: p.(W333Mfs∗35)) in three Korean families (F3, F4, F6)
(Table 1). We identified a deletion (exon 1) (in F9). The frameshift
and nonsense mutations resulting in a premature termination
codon and truncated protein are predicted be pathological by
NMD. Similarly, exon 1 deletion is also predicted to be patholog-
ical by NMD.
In F5, we also identified an FRMD7 variant c.875 T > C:p.
(Leu292Pro). Similarly, in F8, we identified a homozygous TYR
variant c.1205G > A:p.(Arg402Gln) (Table 1) (see discussion for
postulated implications).
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Figure 3. Pedigrees of families with SLC38A8 mutations. VEP = visual evoked potentials; TID = trans-illumination defects of the iris; ? = unknown (not performed)..
Clinical characteristics
The pedigrees and summary of clinical characteristics of the
families with SLC38A8 mutations are shown in Fig. 3 and Table 2,
respectively.
Prior to genetic and VEP testing, the provisional clini-
cal diagnoses are shown in Table 2. Only one family (F7) had
a clinical diagnosis of possible FHONDA. Most families had a
suspected diagnosis of PAX6-related phenotype (6/11 patients),
ocular albinism (3/11 patients) or idiopathic IN (1/11 patients).
F3:II-1 had fundus hypopigmentation and F8:II-1 had TID of the
iris. All other patients did not have any evidence of cutaneous
hypopigmentation, iris TID or fundus hypopigmentation. The
best corrected visual acuity (VA) ranged between 0.30 and 0.78
logMAR with a median VA of 0.52 logMAR. The median spherical
equivalent was +0.625 diopters (D) (range: −1.75 to 2.5D) in
the right eye and +0.50D (range: −2.5 to 3.5D) in the left eye.
All patients, except one (F9:II-1) had moderate-to-high with the
rule astigmatism (WTR) (Table 2). Six of the patients (54%) had
strabismus (Table 2). There was no evidence of ASD in any of
the affected family members. All patients had nystagmus, FH
and VEP crossed asymmetry similar to albinism suggestive of
chiasmal misrouting (VEP was not available for family F5).
Nystagmus characteristics
All affected patients had horizontal conjugate nystagmus
with infantile onset (within first 6 months after birth). Eye
movement recordings revealed the characteristic accelerating
slow phase seen in IN (Fig. 4). Bidirectional jerk nystagmus
was the most common type of nystagmus seen (Fig. 4 and
Table 2). Other waveforms included: dual jerk nystagmus
(F1:II-2), pseudopendular with foveating saccades (F2:II-1) and
pendular with foveating saccades (F1:II-1, F6:II-2 and F7:II-3).
Periodic alternating nystagmus (PAN) was identified in F8:II-1
(Fig. 4). The PAN cycle had a periodicity of 190 s. Nystagmus
frequency ranged between 2.0 and 4.7 Hz with a mean of 3.6 Hz.
Nystagmus amplitude ranged between 3.7 and 6.7◦ with a mean
of 4.7◦. Plots of nystagmus amplitude and frequency are shown in
Figure 4.
Foveal hypoplasia
On morphological assessment, none of the patients with
SLC38A8 mutations had a foveal pit or photoreceptor OS
lengthening. The only OCT feature of foveal specialization
observed was ONL widening (grade 3 FH). Thus, all affected
patients had high grades of FH (either grade 3 or 4) (Fig. 5). The
foveal retina was significantly thicker in the SLC38A8 group
(mean ± SD: 322 ± 23.3 μm) compared with the control group
(mean ± SD: 223 ± 14.8 μm; P = 3.42 × 10−13) (Fig. 5). The retinal
layers RNFL, GCL, IPL and INL and OPL were significantly thicker
in patients with SLC38A8 mutations compared with controls
(P < 0.0001, Fig. 5). The ONL and OS were significantly thinner
in patients with SLC38A8 mutations compared with controls
(P < 0.0001, Fig. 5). There was no significant difference in IS
thickness (P = 0.11).
In the parafoveal region, we find a nasotemporal asymme-
try in thickness measurements between patients with SLC38A8
mutations and controls. No significant difference was seen in
total RT in the nasal parafovea (at both 1 and 2 mm away
from the fovea), however, in the temporal parafovea (at both
1 and 2 mm), the SLC38A8 group had significantly reduced RT
compared with controls (P < 0.0001). This was attributed to a
significantly thinner GCL, IPL, INL, OPL, ONL and IS compared
with controls (Fig. 5). Although differences in RNFL were noted
at 1 mm both nasally and temporally, no significant (P > 0.05)
differences were noted at 2 mm away from the fovea.
Ultra-widefield imaging revealed the concentric macular
ring (CMR) sign (Fig. 6) in four patients that had the imaging.
Corresponding OCT scan showed the alternating hypo- and
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Figure 4. (A) Original eye movement recordings showing nystagmus characteristics and waveforms associated with SLC38A8 mutations. Blue arrows show foveating
saccades and green arrow show accelerating slow phase, a characteristic of infantile nystagmus. (B) PAN associated with a SLC38A8 mutation in F8:II-1. Top panel shows
the horizontal velocity trace (in degrees per second). The middle and bottom panels show the horizontal eye position of the left eye (degrees) in a compressed view and
magnified views, respectively. The magnified traces show the different parts of the PAN cycle, initially right beating nystagmus followed by a short quiet phase, which
has pendular nystagmus and subsequently switching to left beating nystagmus. The switch in direction of the PAN cycle is also readily seen in the velocity trace. For
all eye movement traces—a deflection of the trace upwards signifies movement of the eyes to the right and a deflection downwards represents movement of the eye
to the left. Scales for the magnified view are shown in the bottom panel. (C) Bar graph illustrating the mean frequency (Hz) and amplitude (◦) in patients with SLC38A8
mutations. The error bars indicate the standard deviation (SD). Abbreviations: DJ = dual jerk; PPFS = pseudopendular with foveating saccades; BDJ = bidirectional jerk;
PFS = pendular with foveating saccades.
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Figure 5. (A) Foveal tomograms associated with different SLC38A8 mutations. There is no evidence of a foveal pit or photoreceptor OS lengthening. In F1:II-1, F2:II-1
and F7:II-3, there some evidence of ONL widening, consistent with grade 3 foveal hypoplasia. In F8:II-1, there is no ONL widening which is characteristic of grade 4
foveal hypoplasia. (B) Bar graph showing the mean thickness for intra-retinal layers at the fovea for SLC38A8 patients and controls. The error bars indicate SD. (C)
Mean thickness plots of each retinal layer with 95% confidence intervals for SLC38A8 patients (red) and controls (green). X-axis represents distance away from fovea in
the nasal and temporal directions (in microns). For statistical comparisons thickness measurements were compared at the fovea, 1 and 2 mm from fovea in both the
nasal and temporal directions. Levels of significance indicated alongside the relevant position (∗∗∗ = P < 0.001; ∗∗ = P < 0.01; ∗ = P < 0.05; NS = not significant (P > 0.05)).
Abbreviations: RNFL = retinal nerve fibre layer; GCL = ganglion cell layer; IPL = inner plexiform layer; INL = inner nuclear layer; OPL = outer plexiform layer; ONL = outer
nuclear layer; IS = inner segment; OS = outer segment.
hyper-reflective vertical bands in the parafoveal Henle fibre
layer (Fig. 6).
Discussion
In this study, we describe the detailed genetic and phenotypical
characteristics in patients with SLC38A8 mutations. This is
the first study describing the nystagmus characteristics and
comprehensive retinal abnormalities in patients with SLC38A8
mutations. Due to the rarity of this disorder, previous studies
have been limited to case reports (5) or series (4,6,7) with
partial phenotypic data. Thus, it has not been possible to
systematically investigate the phenotypical characteristics asso-
ciated with SLC38A8 mutations. Over the last 7 years since the
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Figure 6. Multimodal imaging highlighting the CMR sign in SLC38A8 mutations. (A) Ultra-widefield fundus imaging from the right and left eyes of F6:II-2. (B) Magnified
(5x) images show concentric rings surrounding expected location of fovea. (C) OCT scans showing foveal hypoplasia and highlighting (yellow arrow) the alternating
hypo- and hyper-reflective vertical bands in the parafoveal Henle fibre layer.
identification of SLC38A8 mutations causing FHONDA (3), a total
of 17 SLC38A8 mutations have been described. We describe a
further 16 SLC38A8 mutations and thus expand the genotypic
spectrum including splice mutations associated with this
disorder. Moreover, we describe for the first-time patients from
Korean descent with SLC38A8 mutations. Taking together the
mutations, we describe in this study with those reported in the
literature, we find that the sixth transmembrane domain in
SLC38A8 is most frequently affected from missense mutations.
We show that this is a highly conserved region of the SLC38A8
protein (Supplementary Material, Fig. S1), suggesting that the
residues within this domain are critical to the normal function-
ing of the protein. Using three-dimensional (3D) modelling, we
also predict that this domain is an alpha-helix residing within
the core of this putative sodium-coupled neutral amino acid
transporter.
Diagnosing FHONDA is challenging. This is partly due to its
rarity and secondly our knowledge of the phenotypic spectrum
is limited. In the original descriptions of FHONDA, ASD features
as a prominent part of the phenotype (2). However, subsequent
reports (4,5,6,7) and certainly in our cohort of patients, we did
not identify any cases of ASD. It was previously hypothesized
that ASD is only seen in severe cases of FHONDA associated
with deletions (5). However, in our cohort, we had five families
(F2, F3, F6, F8 and F9) with predicted truncating mutations with
no ASD. Thus, ASD likely represents a minor association with
this disorder exhibiting variable expressivity. Among Jewish
ethnicities a founder mutation (c.95 T > G; p.(Ile32Ser)) has
been described (4,7), of the nine affected individuals (from
five families described by Weiner et al. (7) and one family
described by Perez et al. (4)) only one (11%) had mild posterior
embryotoxon (7). Considering that the normal prevalence
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of posterior embryotoxon is 6.8% in the general population
and 22.5% in the younger age groups (8), this could also
be a phenocopy. In one of our patients (F8:II-1) (1/11), we
identified mild iris TID. However, careful examination of all
variants in our nystagmus panel revealed a homozygous TYR
variant (c.1205G > A; p.(Arg402Gln)), which could explain the
TID. Subtle TID can also been seen in carriers of albinism.
Similarly, in F5:II-1 and F5:II-2, we also identified an FRMD7
variant (c.875 T > C:p.(Leu292Pro)) (see Table 1), which has
previously been reported (9). Thus both these mutations could
also be contributory to the phenotype and may represent dual
diagnoses. However, there have been no cases of grade 3 or 4 FH
reported with FRMD7 mutations (10). Consistently in all affected
patients with SLC38A8 mutations, we observe: (1) high grade FH
(grade 3 or 4), (2) IN and (3) chiasmal misrouting detected on VEP.
The median VA of our patients with SLC38A8 mutations was 0.52
logMAR. This is similar to the median VA seen in albinism (0.50
logMAR) (1). In PAX6 mutations, the median VA ranges between
0.48 and 1.52 logMAR depending on the type of mutation (33).
In addition to FH, PAX6 mutations can be associated with
keratopathy, cataracts, glaucoma and optic nerve hypoplasia
thus resulting in much more reduced vision compared with
SLC38A8 mutations and albinism (11). In our cohort of patients
with FH and IN, SLC38A8 mutations only accounted for 1%
(3 families/300 unrelated patients) and 2.8% (6 families/211
unrelated patients) in a UK and a Korean tertiary paediatric
ophthalmology department respectively. In a large French
cohort of suspected cases of albinism, SLC38A8 mutations were
identified in 0.4% (4/990) cases (6). This raises the possibility
that SLC38A8 mutations may have a higher disease burden
in Korea. This could be related to the high allele frequency of
c.995dupG variant in Korean and Japanese populations (0.0026
in gnomAD Korean population and 0.0015 in 4.7 K ToMMo
Japanese). Based on our initial clinical examination, most
common provisional diagnoses were PAX6-related phenotype
and ocular albinism. This was due to the significant phenotypic
overlap between these disorders. Typically, PAX6 mutations
are associated with aniridia, however, recent studies have
reported cases with milder phenotypes with minimal to no iris
abnormalities (12,13). Thus from the initial clinical examination
(prior to VEP testing), in the absence of ocular or cutaneous
hypopigmentation, PAX6-related phenotype could be considered
a differential diagnosis. However, once chiasmal misrouting is
established on VEP testing, only albinism and SLC38A8 muta-
tions are considered as differentials. Though hypopigmentation
(ocular and/or cutaneous) is a characteristic of albinism, signif-
icant phenotypic heterogeneity is associated with albinism (1),
thus making the diagnosis more challenging. We have devised
a diagnostic algorithm, which can be helpful in prioritizing
differential diagnoses and investigations (Fig. 7). The advent of
targeted re-sequencing IN panels (14,15) can potentially obviate
the need for the battery of tests these patients often undergo
(14). However, the main disadvantages of next generation
sequencing (NGS) are the lag time to obtaining results and,
in some instances, determining pathogenicity of variants.
Nevertheless, NGS can be a valuable frontline diagnostic tool
as demonstrated in this study where we revised our initial
diagnosis in 10/11 cases, it also provides deeper insight into
the phenotypes seen (as demonstrated for example with patient
F8:II-1) and opportunities for genetic counselling.
We describe for the first time the nystagmus characteris-
tics seen in patients with SLC38A8 mutations. Similar to other
forms of IN (16), the nystagmus is horizontal conjugate with
the characteristic increasing slow phase velocity. Kumar et al.
showed that albinism had a higher proportion of jerk waveforms
in comparison with FRMD7-related IN (17). In most patients
with SLC38A8 mutations, we observe a jerk nystagmus. How-
ever, we also describe pendular nystagmus with foveating sac-
cades in three patients (F1:II-1, F6:II-2 and F7:II-3). The period-
icity and features of PAN we describe in F8:II-1 are similar to
what has been documented with albinism and FRMD7 mutations
(17,18,19). Previous work has shown that the frequency of nystag-
mus is significantly different between albinism (mean = 3.3 Hz)
and FRMD7 mutations (mean = 4.3 Hz), in our study, we find that
the mean frequency in the SLC38A8 group is 3.6 Hz. Thus, within
the same range as other forms of IN. The shared characteristics
between different forms of IN has been hypothesized to arise
from failure of the smooth-pursuit damping circuitry to prop-
erly calibrate during early development (20,21). Recent work by
Winkelman et al. show that congenital stationary night blind-
ness (CSNB) in humans and a nyx mouse model (nob mice) have
horizontal nystagmus with a frequency of 4–7 Hz, interestingly
the ON direction-selective ganglion cells (GC) that project to the
accessory optic system had electrical oscillations at the same
frequency as the ocular oscillations. They propose the origin
for these oscillations is presynaptic to GC and arise from AII
amacrine cells (22). These cells generate intrinsic oscillations
(23) that drive oscillatory firing of ON-and OFF-GCs in antiphase
(24). Moreover, pharmacological modulation of the oscillatory
frequency of these cells also results in modulation of the nys-
tagmus frequency in nob mice (22). SLC38A8 is expressed within
the plexiform layers in the retina (3), however, it is not known if
it localizes to a specific retinal cell type. Further work is needed
to understand whether the findings by Winkelman et al. (22) can
be extended to other forms of IN including nystagmus associated
with SLC38A8 mutations.
Most of our patients (10/11) had significant WTR astigma-
tism. This is an interesting observation we report and compari-
son with previous cases (Supplementary Material, Table S1), we
find that all have significant WTR astigmatism. Taken together,
this suggests that patients with SLC38A8 mutations almost
always have significant WTR astigmatism. Previous work on
the distribution of refractive errors between idiopathic IN and
albinism showed that albinism was more commonly associated
with significant astigmatism (primarily WTR) when compared
with idiopathic nystagmus (25). Furthermore, longitudinal data
from IN syndrome (INS) show meridional emmetropization in
children with INS and WTR astigmatism (26).
Using OCT, we have been able to quantify the degree of
arrested retinal development in patients with SLC38A8 muta-
tions for the first time. Interestingly, all the patients in our
study had high grades of FH (either grade 3 or 4) (27). Reviewing
literature, we are able to identify OCT scans available (n = 9 foveal
scans) in a few of the SLC38A8 mutation reports (3,4,5,7). We
graded the available scans and find that all patients had either
grade 3 (n = 6) or grade 4 FH (n = 3) (3,4,5,7). Taken together this
means that the retinal phenotype is more severe in SLC38A8
mutations suggestive of an earlier foveal developmental arrest,
hence, we see no signs foveal pit formation or cone outer seg-
ment lengthening. In albinism, PAX6 mutations and other iso-
lated cases we find a larger spectrum of FH (grades 1–4) (27).
We also find that the foveal outer segment thickness reduced
significantly in the SLC38A8 group, which morphologically is
seen as a lack of OS lengthening and thus cone specialization.
Previous work in albinism has shown that the OS length is a
surrogate marker of peak foveal cone density (28). Thus, we
hypothesize that the reduced OS length in SLC38A8 mutations
likely represents a reduced foveal cone density. This is consistent
Human Molecular Genetics, 2020, Vol. 29, No. 18 2999
Figure 7. Clinical diagnostic algorithm for abnormal retinal development. The hallmark of typical foveal hypoplasia is continuation of inner retinal layers posterior to
the foveola. Outer retinal changes or abnormal lamination suggests an inherited retinal dystrophy (IRD). Electroretinogram (ERG) or IRD gene panels can differentiate
between the IRD subtypes. FH or IN gene panels can readily differentiate the genetic subtypes that can cause FH. In the absence of genetic panels, VEP is helpful in
broadly differentiating the diagnoses based on chiasmal misrouting. In some cases of albinism∗ (hypomorphic mutations or carriers), normal VEP responses maybe
present. ONH = optic nerve hypoplasia, IIN = idiopathic infantile nystagmus.
with SLC38A8 immunohistochemistry data, which show protein
expression in plexiform and photoreceptor layers (3). In the
parafovea, we report nasotemporal asymmetry of total retinal
thickness with the temporal parafovea significantly thinner in
the SLC38A8 group compared with controls. This is due to the
asymmetrical developmental sequence within the retina, the
temporal (temporal to incipient fovea) and peripheral retina are
slower to develop and differentiate compared with the central
retina (29). As the fovea pit forms, there is centrifugal displace-
ment of the inner retinal layers (27,30), however, this develop-
mental event does not occur in SLC38A8 mutations. Further com-
parisons with other forms of FH are important to differentiate
whether different mechanisms for arrested retinal development
exist.
We also report for the first time that the CMR sign is present
in SLC38A8 mutations. This sign was initially identified using
infrared reflectance imaging and reported in FH associated with
albinism and aniridia (31). Recently, it was also shown using
ultra-wide field imaging and provided evidence to suggest that
the concentric rings seen are due to alternating hypo- and hyper-
reflective vertical bands in the parafoveal Henle fibre layer.
Moreover, the horizontal diameter of the largest outer ring sig-
nificantly correlates to the FH grading and VA (32). The presence
of CMR in another disorder (SLC38A8 mutations) associated with
FH expands the spectrum of diseases associated with this sign.
In conclusion, we expand on the genotypic and phenotypic
spectrum of SLC38A8 mutations. We describe for the first time
the nystagmus characteristics and quantify the retinal abnor-
malities associated with this disorder. SLC38A8 mutations share
similar nystagmus characteristics to other forms of IN suggest-
ing a common pathophysiological mechanism. However, the
degree of arrested retinal development is more severe and quan-
titative measurements show reduced thickness of the cone pho-




As part of a large-scale genotyping project, patients with IN
(n = 511) were recruited at one centre in the UK (University Hos-
pitals of Leicester) and two centres in Korea (Yonsei University
College of Medicine and University of Ulsan College of Medicine)
over a period of 5 years (2014–2019). Informed consent was
obtained from all participants involved. The study was approved
with a local ethics committee and all aspects of the study were
conducted in accordance with the Tenets of the Declaration of
Helsinki.
The details of our pilot genotyping project have been
previously described (14,15). Briefly, this included extraction of
genomic DNA from saliva samples (DNA Genotek OG-500 and
OG-575 Oragene saliva kits (Ottawa, Ontario, Canada)) or periph-
eral blood and subsequently performing targeted NGS using our
nystagmus gene capture panels or whole exome sequencing.
Our nystagmus gene panels included all known nystagmus
genes described in the literature (14,15). Our initial panels were
revised to also include the recently identified nystagmus gene,
AHR, mutations of which we have described to be causative
of IN and FH (33). Our aim was to identify the prevalence of
SLC38A8 mutations in our cohorts and describe the phenotypical
characteristics.
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Variant filtering and classification
The pathogenicity of missense variants was predicted using in
silico prediction algorithms, including SIFT, PolyPhen2, FATHMM
and CADD (34). Splice site analysis was performed using the
MaxEntScan, NNSPLICE (Neural Network Splice Prediction),
Human Splice Finder, GeneSplicer and SpliceFinder-like algo-
rithms implemented in the Alamut Visual software (Interactive
Biosoftware, Rouen, France). Segregation analysis was performed
in all families except F5 (father (F5:I-1) was not available for
genetic testing). The interpretation of variants followed the
five-tier classification system recommended by the ACMG and
Genomics and the Association for Molecular Pathology (Table 1)
(35). The exact 3D structure of SLC38A8 protein is unknown,
thus we used I-TASSER v5.1 (36,37) deployed within our high-
performance computing cluster, ALICE to predict the SLC38A8
protein 3D structure and map the amino acid substitutions
from missense mutations. I-TASSER is considered one of the
best protein structure prediction algorithms, which uses meta-
threading and ab initio modelling methods to match fragments
of the protein sequence onto the 3D structure of other solved
proteins deposited in the protein data bank (PDB: https://www.
rcsb.org/) (36,37). Subsequently, we also modelled the missense
mutations using STRUM (15) predicting stability changes (G)
of SLC38A8 missense mutations. Where the Gibbs free energy
gap difference (G = Gm – Gw) between the mutant (Gm) and
wild type (Gw) protein is a measure of how the mutation affects
protein stability. A G below zero means that the mutation
causes destabilization; otherwise, it induces stabilization (38).
Phenotyping
All subjects underwent detailed ophthalmic examination and
investigations to determine the phenotypical characteristics.
This included a full orthoptic assessment, anterior segment
slit lamp examination to identify TID of the iris and ASD.
Fundoscopy and optical coherence tomography (OCT) was
performed to identify FH. OCT was performed using either
Envisu C2300 (Leica Microsystems, Wetzlar, Germany) or
Heidelberg Spectralis (Heidelberg Engineering, Heidelberg,
Germany). A 3D horizontal raster scan protocol (AxB scans: 600
x 80; scan window 12 x 8 mm), centred at the macula (39,40).
The central foveal B-scan was selected based on the scan with
the deepest foveal pit. In the absence of a foveal, pit features of
cone photoreceptor specialization were used (27,41). Conversion
factors for both lateral (0.989) and axial (0.975) measurements
were applied to Spectralis tomograms to allow translation of
quantitative data across our OCT platforms (42). The retinal
layers were segmented using a semi-automated ImageJ macro
as described (39,40). Retinal thickness measurements obtained
were: nerve fibre layer (NFL), GC layer (GCL), inner plexiform
layer (IPL), inner nuclear layer (INL), outer plexiform layer (OPL),
outer nuclear layer (ONL), inner segment (IS), outer segment
(OS) and total retinal thickness (RT). For purposes of statistical
comparisons, measurements were extracted from five positions:
foveal centre, 1 and 2 mm away from the fovea in the nasal and
temporal directions. We have previously shown good reliability
and reproducibility of retinal thickness measurements from
patients with nystagmus (43). Control data (age and gender
matched) (n = 18; 12 male, 6 female, mean age ± SD 14.9 ± 7.1)
were obtained from the Leicester OCT normative dataset.
The control group had no known eye pathology, systemic
disease or previous intraocular surgery. There was no history
of prematurity in both the SLC38A8 and control group. OCT
images were graded using the Foveal Hypoplasia Grading Scale
(27) with Grade 1 subdivided into 1a and 1b as per Wilk et al. (44).
This has prognostic value in preverbal children with nystagmus
(45). VEP (ISCEV standards) were used to assess misrouting of
retinal GC axons at the optic chiasm. All patients except F5:II-
1 and F5:II-2 (Table 2) underwent VEP recordings as per ISCEV
standards (46). Patients had a multichannel VEP with either
a pattern onset/offset stimulus (F7:II-3, F8:II-1 and F9:II-1) or
a flash stimulus (F1-F4 and F6, see Table 2). Eye movement
recordings were obtained using an infra-red video pupil tracker
(Eyelink II, SR Research, Osgoode, Canada and SLMED, Seoul,
Korea). Nystagmus waveform at primary position was classified
into 12 categories (Dell’Osso and Daroff Classification) (47).
An extended fixation task was utilized for detection of PAN
as described (19). To assess whether the CMR sign (31,32,48) is
present in patients with SLC38A8 mutations and FH, we obtained
ultra-widefield fundus images (Optos PLC, Dunfermline, UK) in
four eyes of two patients with SLC38A8 mutations.
Statistical analyses
Statistical analysis was performed using IBM SPSS Statistics soft-
ware (version 24, IBM Corp.). A generalized linear mixed model
was used to determine significant differences in retinal layer
thickness measurements between patients and controls. Within
the model, eye (left vs right) was assigned as a repeated mea-
sure, fixed factor was the diagnosis (patients vs controls) and
random factors included age, gender, ethnicity and refraction.
Bonferroni correction was applied for multiple testing. P < 0.05
was considered statistically significant.
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Supplementary Material is available at HMG online.
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